These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets. Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444 [TBL] [Abstract][Full Text] [Related]
3. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals. Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362 [TBL] [Abstract][Full Text] [Related]
4. Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. Pu SY; Xiao F; Schor S; Bekerman E; Zanini F; Barouch-Bentov R; Nagamine CM; Einav S Antiviral Res; 2018 Jul; 155():67-75. PubMed ID: 29753658 [TBL] [Abstract][Full Text] [Related]
5. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity. Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812 [TBL] [Abstract][Full Text] [Related]
6. Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release. Xiao F; Wang S; Barouch-Bentov R; Neveu G; Pu S; Beer M; Schor S; Kumar S; Nicolaescu V; Lindenbach BD; Randall G; Einav S mBio; 2018 Mar; 9(2):. PubMed ID: 29535204 [TBL] [Abstract][Full Text] [Related]
7. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents. Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity. Verdonck S; Pu SY; Sorrell FJ; Elkins JM; Froeyen M; Gao LJ; Prugar LI; Dorosky DE; Brannan JM; Barouch-Bentov R; Knapp S; Dye JM; Herdewijn P; Einav S; De Jonghe S J Med Chem; 2019 Jun; 62(12):5810-5831. PubMed ID: 31136173 [TBL] [Abstract][Full Text] [Related]
9. Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly. Neveu G; Barouch-Bentov R; Ziv-Av A; Gerber D; Jacob Y; Einav S PLoS Pathog; 2012; 8(8):e1002845. PubMed ID: 22916011 [TBL] [Abstract][Full Text] [Related]
10. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies. Karim M; Saul S; Ghita L; Sahoo MK; Ye C; Bhalla N; Lo CW; Jin J; Park JG; Martinez-Gualda B; East MP; Johnson GL; Pinsky BA; Martinez-Sobrido L; Asquith CRM; Narayanan A; De Jonghe S; Einav S Antiviral Res; 2022 Aug; 204():105367. PubMed ID: 35738348 [TBL] [Abstract][Full Text] [Related]
11. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses. Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611 [TBL] [Abstract][Full Text] [Related]
12. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498 [TBL] [Abstract][Full Text] [Related]
13. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase. Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888 [TBL] [Abstract][Full Text] [Related]
14. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Lupberger J; Zeisel MB; Xiao F; Thumann C; Fofana I; Zona L; Davis C; Mee CJ; Turek M; Gorke S; Royer C; Fischer B; Zahid MN; Lavillette D; Fresquet J; Cosset FL; Rothenberg SM; Pietschmann T; Patel AH; Pessaux P; Doffoël M; Raffelsberger W; Poch O; McKeating JA; Brino L; Baumert TF Nat Med; 2011 May; 17(5):589-95. PubMed ID: 21516087 [TBL] [Abstract][Full Text] [Related]
15. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking. Blaising J; Lévy PL; Polyak SJ; Stanifer M; Boulant S; Pécheur EI Antiviral Res; 2013 Oct; 100(1):215-9. PubMed ID: 23981392 [TBL] [Abstract][Full Text] [Related]
16. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines. Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544 [TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase. Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682 [TBL] [Abstract][Full Text] [Related]
18. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly. Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043 [TBL] [Abstract][Full Text] [Related]
19. Development of a broad-spectrum antiviral with activity against Ebola virus. Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection. Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]